Dan Greenberg is an Associate Professor and Chairman of the Department of Health Systems Management at the Faculty of Health Sciences and the Guilford-Glaser Faculty of Business and Management at Ben-Gurion University of the Negev in Israel, where he teaches on comparative healthcare systems, health technology assessment, and economic evaluation of technologies in healthcare. Since 2008, he is also affiliated with the Center for the Evaluation of Value and Risk in Health (CEVR) at The Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, Boston, MA, and is an adjunct faculty at the Tufts University School of Medicine.
During 2001-2004 Dr. Greenberg completed a 3-year post-doctoral research fellowship at the Harvard Clinical Research Institute & Cardiovascular Division, Beth Israel Deaconess Medical Center, and Harvard Medical School, initially as a Fulbright Scholar, and was a Visiting Scientist at the Department of Health Policy and Management at the Harvard School of Public Health. His research focuses on economic evaluation of healthcare technologies, health technology policy, medical decision-making and outcomes research. He has conducted economic evaluations for various medical interventions and contributed to the literature on the willingness to pay for cardiovascular interventions, diffusion of innovations, and the use of economic evaluations for coverage and reimbursement decisions at the national level. Dr. Greenberg authored or co-authored over 50 papers and book chapters and published his work in leading medical and health policy journals, such as the British Medical Journal, Annals of Internal Medicine, Journal of the National Cancer Institute, Health Affairs, and Value in Health. Dan is a co-founder and the former President of the Israeli Society for Pharmacoeconomics and Outcomes Research (ISPOR-Israel), and is currently coeditor of Value in Health, the official journal of ISPOR. Dr. Greenberg received his doctorate degree from Ben-Gurion University of the Negev in 2001.